Boston Scientific has started enrollment in the OMEGA clinical trial to evaluate the safety and effectiveness of its Omega Platinum...
Boston Scientific Corporation has received FDA approval for the REBEL Platinum Chromium Coronary Stent System, the company's latest generation bare-metal...
Biotronik announced it has received FDA approval for its Pro-Kinetic Energy cobalt chromium (CoCr) coronary stent system. The company gained...
The FDA has given approval for the Promus Premier Everolimus-Eluting Platinum Chromium Coronary Stent System, from Boston Scientific, for treating...
Boston Scientific has reported results of the PLATINUM Diversity study to evaluate the clinical outcomes of the Promus Premier Everolimus-Eluting...
The novel cobalt-chromium-based zotarolimus-eluting stent (ZES) ReSolute Integrity stent from Medtronic is non-inferior to a platinum-chromium-based everolimus- eluting stent (EES),...
Boston Scientific has received CE Mark approval for the Promus Premier everolimus-eluting platinum chromium Coronary Stent System, the company's next-generation...
The ION Paclitaxel-Eluting Platinum Chromium Coronary Stent System and TAXUS Liberte Paclitaxel-Eluting Coronary Stent System, from Boston Scientific, have received...
Boston Scientific reported positive, long-term data from the EVOLVE Trial of the Synergy Everolimus-Eluting Bioabsorbable Polymer Platinum Chromium Coronary Stent...
Boston Scientific Corporation and The Medicines Company announced a co-promotion agreement for the Boston Scientific Promus Premier Everolimus-Eluting Platinum Chromium...